Immunome (IMNM) Amortizatization of Intangibles (2022 - 2026)
Immunome's (IMNM) quarterly Amortizatization of Intangibles came in at $816000.0 in Q3 2025, down 44.6% YoY from $1.5 million in Q3 2024, and down 32.28% on a QoQ basis from $1.2 million in Q2 2025.
Powered by 
Analysis
Immunome (IMNM) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Immunome (IMNM) has 3 years of Amortizatization of Intangibles data on file, last reported at $816000.0 in Q3 2025.
- Quarterly Amortizatization of Intangibles fell 44.6% year-over-year to $816000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 36.43% YoY) and the FY2025 annual result came in at $2.8 million, down 2.07% from the prior year.
- Amortizatization of Intangibles eased to $816000.0 in Q3 2025, from $1.2 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.5 million in Q3 2024 to a low of $352000.0 in Q2 2024.
- A 3-year average of $822750.0 and a median of $817000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The widest YoY moves for Amortizatization of Intangibles: up 242.33% in 2025, down 44.6% in 2025.
- Tracing IMNM's Amortizatization of Intangibles over 3 years: stood at $844000.0 in 2023, then slumped by 36.49% to $536000.0 in 2024, then surged by 52.24% to $816000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $816000.0 (Q3 2025), $1.2 million (Q2 2025), and $818000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 4.33 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 678,000.00 |
| 10 | Immunome | 3.03 Bn | 2.51 Bn | - | 296,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 296,000.00 |
| Mar 31, 2026 | 150,000.00 |
| Sep 30, 2025 | 816,000.00 |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 818,000.00 |
| Dec 31, 2024 | 536,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | 538,000.00 |
| Dec 31, 2023 | 844,000.00 |
| Sep 30, 2023 | -442,000.00 |
| Jun 30, 2023 | 56,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Dec 31, 2022 | 165,000.00 |
| Sep 30, 2022 | 11,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 25,000.00 |